Patents by Inventor Shuixian ZHAO

Shuixian ZHAO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of trezastilbenoside in manufacture of product for treating and/or preventing disease of respiratory system
    Patent number: 11744841
    Abstract: The present disclosure belongs to the biopharmaceutical field, and discloses uses of Trezastilbenoside in manufacture of a product for treating and/or preventing a disease of respiratory system, and particularly uses of Trezastilbenoside in manufacture of a product for treating and/or preventing a disease of respiratory system with symptoms of cough and/or expectoration and/or asthma. As indicated by the test results of the present disclosure, Trezastilbenoside has significant efficacy of relieving cough, eliminating phlegm, relieving asthma and anti-inflammation, and has a potential therapeutic effect on respiratory system diseases, thus possessing broad prospects in clinical application.
    Type: Grant
    Filed: December 29, 2020
    Date of Patent: September 5, 2023
    Assignee: KPC PHARMACEUTICALS, INC.
    Inventors: Yidan Liu, Xujuan Yang, Xi Huang, Qing Huang, Shuixian Zhao, Guoguang Liu, Jianhua Shang
  • USE OF TREZASTILBENOSIDE IN MANUFACTURE OF PRODUCT FOR TREATING AND/OR PREVENTING DISEASE OF RESPIRATORY SYSTEM
    Publication number: 20210196736
    Abstract: The present disclosure belongs to the biopharmaceutical field, and discloses uses of Trezastilbenoside in manufacture of a product for treating and/or preventing a disease of respiratory system, and particularly uses of Trezastilbenoside in manufacture of a product for treating and/or preventing a disease of respiratory system with symptoms of cough and/or expectoration and/or asthma. As indicated by the test results of the present disclosure, Trezastilbenoside has significant efficacy of relieving cough, eliminating phlegm, relieving asthma and anti-inflammation, and has a potential therapeutic effect on respiratory system diseases, thus possessing broad prospects in clinical application.
    Type: Application
    Filed: December 29, 2020
    Publication date: July 1, 2021
    Applicant: KPC PHARMACEUTICALS, INC.
    Inventors: Yidan LIU, Xujuan YANG, Xi HUANG, Qing HUANG, Shuixian ZHAO, Guoguang LIU, Jianhua SHANG